Method for producing tumor-infiltrating lymphocytes and uses thereof in immunotherapy
DE602019069740T2Active Publication Date: 2025-05-07IOVANCE BIOTHERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- DE602019069740
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-09-20
- Filing Date
- 2019-11-04
- Publication Date
- 2025-05-07
- Estimated Expiration
- 2039-11-04
AI Technical Summary
Technical Problem
Current TIL manufacturing processes are limited by length, cost, sterility concerns, and the need for improved scalability and potency of TIL preparations for cancer treatment.
Method used
A novel TIL expansion process that includes antigen-presenting feeder cells from the initiation of expansion, reducing the overall time and enhancing the expansion process.
Benefits of technology
This process results in a substantial reduction in the time required for TIL expansion, improving the cost-effectiveness and scalability of TIL manufacturing while producing more potent anti-cancer TIL preparations.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.